Skip to main content

Twin Securities, Inc.

13F filer · CIK 0001351351
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$223MU.S. long equity reported on 13F
Positions116 new · 10 closed
Net flow last quarter-$9.48MBuys minus sells
Top 10 positions weight87.6%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202611 positions
EAElectronic Arts Inc.$108M48.49%Not reported+18.2%Q4 2025
WBDWarner Bros. Discovery, Inc.$21.5M9.63%0.03%-37.9%Q2 2022
APGEApogee Therapeutics, Inc.$15.9M7.13%0.16%NewQ2 2026
ROKURoku, Inc$14.6M6.53%0.07%NewQ2 2026
KVUEKenvue Inc.$14.4M6.46%0.04%+57.1%Q3 2023
BLDTopBuild Corp$14.2M6.34%0.14%NewQ2 2026
PSKYParamount Skydance Corp$3.3M1.48%0.03%NewQ2 2026
OGNOrganon & Co.$2.37M1.06%0.07%NewQ2 2026
TICTIC Solutions, Inc.$626K0.28%0.04%Not reportedQ1 2025
RNAAtrium Therapeutics, Inc.$357K0.16%0.16%-46.9%Q1 2026
NSCNorfolk Southern Corp$205K0.09%0.00%Not reportedQ4 2025
Q1 2026Reported May 15, 202615 positions
EAElectronic Arts Inc.$91.1M44.21%Not reported+86.4%Q4 2025
WBDWarner Bros. Discovery, Inc.$35.7M17.32%0.05%+16.6%Q2 2022
CWANClearwater Analytics Holdings, Inc.$27.5M13.36%Not reported+2260.6%Q4 2025
HOLXHologic Inc$13.5M6.57%0.08%+111.8%Q4 2025
KVUEKenvue Inc.$8.28M4.02%0.03%+18.5%Q3 2023
ACLXArcellx, Inc.$6.2M3.01%0.09%NewQ1 2026
TERNTerns Pharmaceuticals, Inc.$6.11M2.97%0.10%NewQ1 2026
APLSApellis Pharmaceuticals, Inc.$5.13M2.49%0.10%NewQ1 2026
RVMDRevolution Medicines, Inc.$3.75M1.82%0.02%NewQ1 2026
TTWOTake Two Interactive Software Inc$1.28M0.62%0.00%NewQ1 2026
DAWNDay One Biopharmaceuticals, Inc.$678K0.33%0.03%NewQ1 2026
RNAAtrium Therapeutics, Inc.$667K0.32%0.29%+36.7%Q1 2026
TICTIC Solutions, Inc.$509K0.25%0.04%Not reportedQ1 2025
MANUManchester United plc$251K0.12%Not reported+2.4%Q1 2024
SGRYSurgery Partners, Inc.$119K0.06%0.01%-94.1%Q1 2025
Q4 2025Reported Feb 17, 202615 positions
EXKEndeavour Silver Corp$49.1M18.77%0.18%NewQ4 2025
EAElectronic Arts Inc.$49M18.73%Not reportedNewQ4 2025
WBDWarner Bros. Discovery, Inc.$32.1M12.28%0.05%+773.0%Q2 2022
RNAMAvidity Biosciences, Inc.$26.3M10.07%0.24%NewQ4 2025
CFLTConfluent, Inc.$15.3M5.84%0.46%NewQ4 2025
NSCNorfolk Southern Corp$7.28M2.78%0.01%NewQ4 2025
KVUEKenvue Inc.$7M2.67%0.02%Not reportedQ3 2023
HOLXHologic Inc$6.3M2.41%0.04%NewQ4 2025
DAYDayforce, Inc.$2.71M1.04%0.02%NewQ4 2025
SGRYSurgery Partners, Inc.$2.63M1.01%0.13%+19.2%Q1 2025
CWANClearwater Analytics Holdings, Inc.$1.19M0.45%Not reportedNewQ4 2025
CDTXCidara Therapeutics, Inc.$1.08M0.41%0.02%NewQ4 2025
TICTIC Solutions, Inc.$782K0.30%0.04%-37.2%Q1 2025
MLYSMineralys Therapeutics, Inc.$607K0.23%0.02%NewQ4 2025
MANUManchester United plc$232K0.09%Not reported-1.3%Q1 2024
Q3 2025Reported Nov 14, 202511 positions
VRNAVerona Pharma plc$53.5M26.58%0.07%NewQ3 2025
MRUSMerus N.V.$29.2M14.52%0.41%NewQ3 2025
COOPCooperative Bankshares Inc$25.8M12.82%Not reportedNewQ3 2025
SPRSpirit AeroSystems Holdings, Inc.$9.97M4.96%0.22%+1.9%Q4 2024
SGRYSurgery Partners, Inc.$3.09M1.54%0.11%-72.1%Q1 2025
WNSWNS (Holdings) Limited$2.5M1.24%0.08%NewQ3 2025
WBDWarner Bros. Discovery, Inc.$2.49M1.24%0.01%Not reportedQ2 2022
TICTIC Solutions, Inc.$1.64M0.81%0.06%-71.7%Q1 2025
TRMLTourmaline Bio, Inc.$1.59M0.79%0.13%NewQ3 2025
PLYMPlymouth Industrial REIT, Inc.$450K0.22%0.05%NewQ3 2025
MANUManchester United plc$224K0.11%Not reported+21.6%Q1 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.